转染
毛皮
普吕卡贡
胰高血糖素样肽-1
互补DNA
基因传递
分子生物学
生物
质粒
体内
2型糖尿病
基因
信使核糖核酸
内科学
内分泌学
糖尿病
医学
生物化学
遗传学
酶
作者
Seungjoon Oh,Minhyung Lee,Kyung Soo Ko,Sun-A Choi,Sung Wan Kim
标识
DOI:10.1016/s1525-0016(03)00036-4
摘要
Glucagon-like peptide-1 (GLP-1) is a potent insulinotrophic hormone, which makes GLP-1 an attractive candidate for the treatment of type 2 diabetes. However, the short plasma half-life of the active forms of GLP-1 poses an obstacle to the sustained delivery of this peptide. In this study, we evaluated the effect of GLP-1 gene delivery both in vitro and in vivo using a new plasmid constructed with a modified GLP-1 (7-37) cDNA. This cDNA contains a furin cleavage site between the start codon and the GLP-1 coding region. The expression of the GLP-1 gene was driven by a chicken beta-actin promoter (pbetaGLP1). The level of the GLP-1 mRNA was evaluated by RT-PCR 24 h after transfection. The in vitro results showed a dose-dependent expression of GLP-1. Coculture assay of the GLP-1 plasmid-transfected cells with isolated rat islet cells demonstrated that GLP-1 increased insulin secretion by twofold, compared to controls during a hyperglycemic challenge. A single injection of polyethyleneimine/pbetaGLP1 complex into ZDF rats resulted in increasing insulin secretion and decreasing blood glucose level that was maintained for 2 weeks. This GLP-1 gene delivery system may provide an effective and safe treatment modality for type 2 diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI